Sodium Channel Type II Activators comprise a diverse array of chemical compounds that indirectly enhance the channel's functional activity through various mechanisms, primarily focused on modulating the channel's gating and ion conductance properties. Tetrodotoxin, Aconitine, Veratridine, and Batrachotoxin, all exhibit their effects by binding to the Sodium Channel Type II. Tetrodotoxin uniquely increases the channel's sensitivity by blocking sodium influx, while Aconitine and Veratridine prolong the open state of the channel, enhancing sodium ion conductance. Batrachotoxin takes this a step further by irreversibly opening the channel, thereby significantly increasing sodium ion influx. These actions collectively heighten the functional capacity of the Sodium Channel Type II in neuron excitation. Conversely, A-803467, Lacosamide, and Ranolazine modulate the channel's activity through indirect pathways. A-803467's selective inhibition of Nav1.8 channels leads to a compensatory increase in Sodium Channel Type II activity, whereas Lacosamide enhances the slow inactivation, and Ranolazine affects the late phase of the sodium current, both contributing to a more efficient recovery and availability of the channel for activation.
In addition to these mechanisms, other compounds like Phenytoin, Carbamazepine, Oxcarbazepine, Lamotrigine, and Ziconotide indirectly enhance Sodium Channel Type II functionality by stabilizing its gating dynamics. Phenytoin and Lamotrigine prevent excessive activation by inhibiting the prolonged open state of the channel, thereby stabilizing its normal operation. Carbamazepine and Oxcarbazepine similarly stabilize the inactive state of the channel, preventing abnormal, prolonged activation and enhancing the channel's responsiveness. Ziconotide, although primarily a calcium channel blocker, indirectly augments Sodium Channel Type II's activity by initiating compensatory mechanisms in neurons to maintain excitability and signal propagation. Through these multifaceted approaches, each of these activators contributes to the enhanced functional activity of Sodium Channel Type II, crucial for effective neuronal signaling and excitability.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aconitine | 302-27-2 | sc-202441 sc-202441A sc-202441B sc-202441C sc-202441D | 25 mg 50 mg 100 mg 250 mg 500 mg | $300.00 $450.00 $650.00 $1252.00 $2050.00 | ||
Aconitine, an alkaloid toxin, binds to and opens Sodium Channel Type II. This interaction keeps the channel in an open state for longer durations, thereby enhancing its functional activity in propagating action potentials. | ||||||
Veratridine | 71-62-5 | sc-201075B sc-201075 sc-201075C sc-201075A | 5 mg 10 mg 25 mg 50 mg | $80.00 $102.00 $197.00 $372.00 | 3 | |
Veratridine binds to and stabilizes the open state of Sodium Channel Type II, enhancing its activity by increasing sodium ion conductance and prolonging the action potential phase. | ||||||
A-803467 | 944261-79-4 | sc-201068 sc-201068B sc-201068A | 10 mg 25 mg 50 mg | $87.00 $184.00 $342.00 | 1 | |
A-803467 selectively inhibits the Nav1.8 sodium channel, indirectly leading to a compensatory increase in Sodium Channel Type II activity as a mechanism to maintain neuronal excitability. | ||||||
Ranolazine | 95635-55-5 | sc-212769 | 1 g | $107.00 | 3 | |
Ranolazine preferentially affects the late phase of the sodium current in Sodium Channel Type II, indirectly leading to a more efficient recovery from inactivation and thus enhancing the channel's overall functionality. | ||||||
5,5-Diphenyl Hydantoin | 57-41-0 | sc-210385 | 5 g | $70.00 | ||
Phenytoin, by preferentially inhibiting the prolonged open state of Sodium Channel Type II, indirectly leads to an overall enhancement of the channel's normal functioning by preventing excessive activation and subsequent inactivation. | ||||||
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $32.00 $70.00 | 5 | |
Carbamazepine stabilizes the inactive state of Sodium Channel Type II, indirectly enhancing the channel's normal function and responsiveness by preventing abnormal, prolonged activation. | ||||||
Lamotrigine | 84057-84-1 | sc-201079 sc-201079A | 10 mg 50 mg | $118.00 $476.00 | 1 | |
Lamotrigine blocks the prolonged opening of Sodium Channel Type II, enhancing its functional activity by stabilizing the channel's normal operation and preventing excessive activation. | ||||||